(Q52020724)

19 April 2018

title

Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease. (English)

1 reference

19 April 2018

author name string

D K Lahiri

1

1 reference

19 April 2018

M R Farlow

2

1 reference

19 April 2018

N Hintz

3

1 reference

19 April 2018

T Utsuki

4

1 reference

19 April 2018

N H Greig

5

1 reference

19 April 2018

publication date

1 January 2000

1 reference

19 April 2018

Acta neurologica Scandinavica. Supplementum

published in

1 reference

19 April 2018

volume

176

1 reference

19 April 2018

page(s)

60-67

1 reference

19 April 2018

Alzheimer's disease: genotypes, phenotypes, and treatments

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

The origins of Alzheimer disease: a is for amyloid.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Alzheimer's disease. Pinning down phosphorylated tau.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Translating cell biology into therapeutic advances in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Purification and cloning of amyloid precursor protein beta-secretase from human brain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Alzheimer's disease. The tangled tale of tau.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Oral physostigmine treatment of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: distribution of enzyme activities and some behavioral implications.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00309.X

7 January 2021

10.1034/J.1600-0404.2000.00309.X

Identifiers

DOI

0 references

PubMed ID

11273593

1 reference

19 April 2018